These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 28901526)
1. MicroRNA‑214 targets Wnt3a to suppress liver cancer cell proliferation. Yang Y; Zhao Z; Hou N; Li Y; Wang X; Wu F; Sun R; Han J; Sun H; Song T; Huang C; Shao Y Mol Med Rep; 2017 Nov; 16(5):6920-6927. PubMed ID: 28901526 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells. Yang Y; Li M; Chang S; Wang L; Song T; Gao L; Hu L; Li Z; Liu L; Yao J; Huang C Mol Med Rep; 2014 Nov; 10(5):2643-8. PubMed ID: 25174704 [TBL] [Abstract][Full Text] [Related]
3. miR-15a-5p suppresses endometrial cancer cell growth via Wnt/β-catenin signaling pathway by inhibiting WNT3A. Wang ZM; Wan XH; Sang GY; Zhao JD; Zhu QY; Wang DM Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4810-4818. PubMed ID: 29164582 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-187 inhibits tumor growth and metastasis via targeting of IGF-1R in hepatocellular carcinoma. Han X; Wang X; Zhao B; Chen G; Sheng Y; Wang W; Teng M Mol Med Rep; 2017 Aug; 16(2):2241-2246. PubMed ID: 28627639 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA‑214 upregulates HIF‑1α and VEGF by targeting ING4 in lung cancer cells. Li Y; Zhao L; Qi Y; Yang X Mol Med Rep; 2019 Jun; 19(6):4935-4945. PubMed ID: 31059086 [TBL] [Abstract][Full Text] [Related]
6. Long Non-Coding RNA Linc-USP16 Functions As a Tumour Suppressor in Hepatocellular Carcinoma by Regulating PTEN Expression. Sui J; Yang X; Qi W; Guo K; Gao Z; Wang L; Sun D Cell Physiol Biochem; 2017; 44(3):1188-1198. PubMed ID: 29179215 [TBL] [Abstract][Full Text] [Related]
7. [Abnormal expression of Wnt3a and inhibiting role of its molecular-targeted intervening in hepatocellular carcinoma]. Sai WL; Yao M; Zheng WJ; Wu MN; Sun JY; Pan LH; Dong ZZ; Yao DF Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):866-871. PubMed ID: 31941241 [No Abstract] [Full Text] [Related]
8. Inhibition of miR‑214 attenuates the migration and invasion of triple‑negative breast cancer cells. Zhang Y; Zhao Z; Li S; Dong L; Li Y; Mao Y; Liang Y; Tao Y; Ma J Mol Med Rep; 2019 May; 19(5):4035-4042. PubMed ID: 30942417 [TBL] [Abstract][Full Text] [Related]
9. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1). Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA‑340 inhibits tumor cell proliferation, migration and invasion, and induces apoptosis in hepatocellular carcinoma. Wang Z; Song D; Huang P Mol Med Rep; 2017 Nov; 16(5):7649-7656. PubMed ID: 28944918 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-150 targets Rho-associated protein kinase 1 to inhibit cell proliferation, migration and invasion in papillary thyroid carcinoma. Cheng L; Zhou R; Chen M; Feng L; Li H Mol Med Rep; 2017 Aug; 16(2):2217-2224. PubMed ID: 28656254 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑144 suppresses tumorigenesis of hepatocellular carcinoma by targeting AKT3. Ma Y; She XG; Ming YZ; Wan QQ; Ye QF Mol Med Rep; 2015 Feb; 11(2):1378-83. PubMed ID: 25370363 [TBL] [Abstract][Full Text] [Related]
13. Sensitization of hepatocellular carcinoma cells to irradiation by miR‑34a through targeting lactate dehydrogenase‑A. Li X; Lu P; Li B; Yang R; Chu Y; Zhang Z; Wan H; Niu C; Wang C; Luo K Mol Med Rep; 2016 Apr; 13(4):3661-7. PubMed ID: 26956717 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-214 acts as a potential oncogene in breast cancer by targeting the PTEN-PI3K/Akt signaling pathway. Wang F; Li L; Chen Z; Zhu M; Gu Y Int J Mol Med; 2016 May; 37(5):1421-8. PubMed ID: 26951965 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA‑214 promotes proliferation and inhibits apoptosis via targeting Bax in nasopharyngeal carcinoma cells. He J; Tang Y; Tian Y Mol Med Rep; 2015 Oct; 12(4):6286-92. PubMed ID: 26239171 [TBL] [Abstract][Full Text] [Related]
16. MiR-1180 promoted the proliferation of hepatocellular carcinoma cells by repressing TNIP2 expression. Zhou X; Zhu HQ; Ma CQ; Li HG; Liu FF; Chang H; Lu J Biomed Pharmacother; 2016 Apr; 79():315-20. PubMed ID: 27044843 [TBL] [Abstract][Full Text] [Related]
17. miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma. El Tayebi HM; Hosny KA; Esmat G; Breuhahn K; Abdelaziz AI FEBS Lett; 2012 Sep; 586(19):3309-16. PubMed ID: 22819824 [TBL] [Abstract][Full Text] [Related]
18. Expression and function of microRNA-27b in hepatocellular carcinoma. He S; Zhang J; Lin J; Zhang C; Sun S Mol Med Rep; 2016 Mar; 13(3):2801-8. PubMed ID: 26846382 [TBL] [Abstract][Full Text] [Related]
19. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554 [TBL] [Abstract][Full Text] [Related]
20. Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway. Lou G; Dong X; Xia C; Ye B; Yan Q; Wu S; Yu Y; Liu F; Zheng M; Chen Z; Liu Y J Exp Clin Cancer Res; 2016 Jan; 35():14. PubMed ID: 26790956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]